These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18180387)

  • 1. Xenotransplantation in orthopaedic surgery.
    Laurencin CT; El-Amin SF
    J Am Acad Orthop Surg; 2008 Jan; 16(1):4-8. PubMed ID: 18180387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Xenotransplantation and the potential risk of xenogeneic transmission of porcine viruses.
    Yoo D; Giulivi A
    Can J Vet Res; 2000 Oct; 64(4):193-203. PubMed ID: 11041495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 3: Porcine islet product manufacturing and release testing criteria.
    Rayat GR; Gazda LS; Hawthorne WJ; Hering BJ; Hosking P; Matsumoto S; Rajotte RV
    Xenotransplantation; 2016; 23(1):38-45. PubMed ID: 26923763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Xenotransplantation: recent developments and futur clinical applications].
    Sgroi A; Morel P; Bühler L
    Rev Med Suisse; 2012 Jun; 8(346):1342-5. PubMed ID: 22792600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenotransplantation of solid organs in the pig-to-primate model.
    Ekser B; Rigotti P; Gridelli B; Cooper DK
    Transpl Immunol; 2009 Jun; 21(2):87-92. PubMed ID: 18955143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses.
    Denner J; Schuurman HJ; Patience C
    Xenotransplantation; 2009; 16(4):239-48. PubMed ID: 19799764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 1: Key ethical requirements and progress toward the definition of an international regulatory framework.
    Cozzi E; Tallacchini M; Flanagan EB; Pierson RN; Sykes M; Vanderpool HY
    Xenotransplantation; 2009; 16(4):203-14. PubMed ID: 19799760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA seeks "comfort factors" before removing hold on porcine xenotransplantation trials.
    Fox JL
    Nat Biotechnol; 1998 Mar; 16(3):224. PubMed ID: 9527996
    [No Abstract]   [Full Text] [Related]  

  • 9. Xenotransplantation: Where do we stand in 2016?
    Puga Yung GL; Rieben R; Bühler L; Schuurman HJ; Seebach J
    Swiss Med Wkly; 2017; 147():w14403. PubMed ID: 28322428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future prospects for xenotransplantation.
    French AJ; Greenstein JL; Loveland BE; Mountford PS
    Reprod Fertil Dev; 1998; 10(7-8):683-96. PubMed ID: 10612477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation: the present status of xenotransplantation and its potential role in the treatment of end-stage cardiac and pulmonary diseases.
    Cooper DK; Keogh AM; Brink J; Corris PA; Klepetko W; Pierson RN; Schmoeckel M; Shirakura R; Warner Stevenson L;
    J Heart Lung Transplant; 2000 Dec; 19(12):1125-65. PubMed ID: 11124485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First update of the International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--Chapter 1: update on national regulatory frameworks pertinent to clinical islet xenotransplantation.
    Cozzi E; Tönjes RR; Gianello P; Bühler LH; Rayat GR; Matsumoto S; Park CG; Kwon I; Wang W; O'Connell P; Jessamine S; Elliott RB; Kobayashi T; Hering BJ
    Xenotransplantation; 2016; 23(1):14-24. PubMed ID: 26940509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and FDA regulations for musculoskeletal allografts: perspective of an orthopaedic surgeon.
    Joyce MJ
    Clin Orthop Relat Res; 2005 Jun; (435):22-30. PubMed ID: 15930917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National policies for xenotransplantation in the USA.
    Bloom ET
    Xenotransplantation; 2007 Jul; 14(4):345-6. PubMed ID: 17669177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenotransplantation literature update May-August, 2007.
    Baertschiger RM; Buhler LH
    Xenotransplantation; 2007 Nov; 14(6):642-52. PubMed ID: 17991153
    [No Abstract]   [Full Text] [Related]  

  • 16. Xenotransplantation--federal regulatory considerations.
    Bloom ET
    Curr Top Microbiol Immunol; 2003; 278():239-51. PubMed ID: 12934947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The perspectives for porcine-to-human xenografts.
    Petersen B; Carnwath JW; Niemann H
    Comp Immunol Microbiol Infect Dis; 2009 Mar; 32(2):91-105. PubMed ID: 18280567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infections after xenotransplantation.
    Nellore A
    Curr Opin Organ Transplant; 2018 Dec; 23(6):628-632. PubMed ID: 30300329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xenotransplantation under FDA spotlight.
    Brower V
    Nat Med; 1998 Feb; 4(2):135-6. PubMed ID: 9461168
    [No Abstract]   [Full Text] [Related]  

  • 20. Xenotransplantation--state of the art.
    Cooper DK
    Front Biosci; 1996 Sep; 1():d248-65. PubMed ID: 9159232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.